500 patients67,039 observations150 daysLIVE

Patient P-03046

Synthetic patientONX-7 · Day 141 · 65–74 · F · baseline S20Open companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Stable
Discontinuation risk
45%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S20
  2. Day 98 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 102 GI-04 recommendedGI Support Protocol GI-04
  4. Day 103 Patient acceptedStarted GI-04 in the companion
  5. Day 111 No meaningful changeGI Support Protocol GI-04

What changed?

Trajectory began diverging from predicted response on Day 98.

Primary contributors, last 14 days
  • GI instability-6
  • Inflammatory activity-6
  • Toxicity-6
  • Nutritional resilience+4
  • Treatment adherence-2

What helped?

  • GI Support Protocol GI-04Day 102
    Result: no meaningful change
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
63%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 82% showed improvement
  • median effect visible after 5 days

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 32/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Mucosal barrier integrity 30
    • Daily logGI symptom score 47 and rising
    • WearableSleep 6.0 h, below personal baseline
  • Inflammatory signalling 25
    • BloodInflammatory load index 47
  • Autonomic recovery 20
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.1 · butyrate capacity 32/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
51 ms
Sleep
5.8 h
Steps
5,470
Resting HR
71 bpm
Daily log: GI score 47, nutritional resilience 46, adherence 68.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0335748%S02CR-01improved50
P-0346547%S17CR-01improved65
P-0326046%S1954
P-0326746%S0562
P-0316645%S20CR-01improved62
P-0335243%S1959
P-0338243%S01GI-04improved56
P-0312341%S14GI-04improved50
P-0320141%S15GI-04improved68
P-0314639%S14GI-04improved53
P-0322539%S19GI-04improved50
P-0327139%S1966